Parasomnias and Movement Disorders of Sleep

ABSTRACT

Neurologists are often enlisted to help diagnose, evaluate, and manage a spectrum of abnormal spells during the night ranging from parasomnias to motor disturbance that span the sleep–wake cycle. Parasomnias are undesirable emotional or physical events that accompany sleep. These events typically occur during entry into sleep from wakefulness, or during arousals from sleep, and are often augmented by the sleep state. Some parasomnias, such as the rapid eye movement (REM) sleep behavior disorder may be extremely undesirable, while others such as somniloquy are often of little concern. The parasomnias include a spectrum of abnormal emotions, movements, behaviors, sensory perceptions, dream mentation, and autonomic activity. Basic physiologic drives, such as sex, hunger, and aggression, may manifest as sleep-related eating, sleep-related sexual behaviors, and sleep-related violence. Parasomnias have a very bizarre nature, but are readily explainable, diagnosable, and treatable. They are hypothesized to be due to changes in brain organization across multiple states of being, and are particularly apt to occur during the incomplete transition or oscillation from one sleep state to another. Parasomnias are often explained on the basis that wakefulness and sleep are not mutually exclusive states, and abnormal intrusion of wakefulness into non-REM (NREM) sleep produces arousal disorders, and intrusion of wakefulness into REM sleep produces REM sleep parasomnias and REM sleep behavior disorder (RBD). Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), two closely related conditions that often result in disturbed sleep onset and sleep maintenance, are also reviewed in this article. Although the mechanisms that underlie idiopathic RLS or PLMD are not fully understood, there is currently substantial evidence that dopaminergic dysfunction is likely involved in both conditions. The discussion will conclude with the “other parasomnias” and sleep-related movement disorders of clinical interest to the neurologist.

KEYWORDS

Parasomnias - sleepwalking - sleep terrors - REM sleep behavior disorder - rhythmic movement disorder - restless legs syndrome - periodic limb movements - diagnosis - treatment

REFERENCES

• 1 Mahowald M W, Ettinger M G. Things that go bump in the night: the parasomnias revisited.  J Clin Neurophysiol. 1990;  7(1) 119-143
• 2 Broughton R. Behavioral Parasomnias. Boston, MA; Butterworth-Heinemann 1998
• 3 Brooks S, Kushida C A. Behavioral parasomnias.  Curr Psychiatry Rep. 2002;  4(5) 363-368
• 4 Mahowald M W, Bornemann M C, Schenck C H. Parasomnias.  Semin Neurol. 2004;  24(3) 283-292
• 5 Mahowald M W. Overview of parasomnias. In: National Sleep Medicine Course. Westchester, IL; American Academy of Sleep Medicine 1999
• 6 Kowey P R, Marinchak R A, Rials S J. Things that go bang in the night.  N Engl J Med. 1992;  327(26) 1884
• 7 Thorpy M J, Glovinsky P B. Parasomnias.  Psychiatr Clin North Am. 1987;  10(4) 623-639
• 8 Stores G. Dramatic parasomnias.  J R Soc Med. 2001;  94(4) 173-176
• 9 Parkes J D. The parasomnias.  Lancet. 1986;  2(8514) 1021-1025
• 10 American AoSM .ICSD-2—The International Classification of Sleep Disorders, Second Edition: Diagnostic and Coding Manual. 2nd ed. Westchester, IL; American Academy of Sleep Medicine 2005: 293
• 11 Mahowald M W, Ettinger M G. Things that go bump in the night: the parasomnias revisited.  J Clin Neurophysiol. 1990;  7(1) 119-143
• 12 The International Classification of Sleep Disorders .Westchester, IL; American Academy of Sleep Medicine 2005
• 13 Fisher C, Kahn E, Edwards A, Davis D M. A psychophysiological study of nightmares and night terrors. I. Physiological aspects of the stage 4 night terror.  J Nerv Ment Dis. 1973;  157(2) 75-98
• 14 Fisher C, Kahn E, Edwards A, Davis D M, Fine J. A psychophysiological study of nightmares and night terrors. 3. Mental content and recall of stage 4 night terrors.  J Nerv Ment Dis. 1974;  158(3) 174-188
• 15 Mahowald M W, Schenck C H. NREM sleep parasomnias.  Neurol Clin. 1996;  14(4) 675-696
• 16 Ohayon M M, Guilleminault C, Priest R G. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders.  J Clin Psychiatry. 1999;  60(4) 268-276, quiz 277
• 17 Parkes J D. The parasomnias.  Lancet. 1986;  2(8514) 1021-1025
• 18 Thorpy M J, Glovinsky P B. Parasomnias.  Psychiatr Clin North Am. 1987;  10(4) 623-639
• 19 Zaiwalla Z. Parasomnias.  Clin Med. 2005;  5(2) 109-112
• 20 Klackenberg G. Somnambulism in childhood—prevalence, course and behavioral correlations. A prospective longitudinal study (6–16 years).  Acta Paediatr Scand. 1982;  71(3) 495-499
• 21 Nino-Murcia G, Dement W C. Psychophysiological and pharmacological aspects of somnambulism and night terrors in children. In: Meltzer HY Psychopharmacology: The Third Generation of Progress. New York; Raven Press 1987: 873-879
• 22 Reid W H, Ahmed I, Levie C A. Treatment of sleepwalking: a controlled study.  Am J Psychother. 1981;  35(1) 27-37
• 23 Mahowald M W, Rosen G M. Parasomnias in children.  Pediatrician. 1990;  17 21-31
• 24 Mahowald M W, Ettinger M G. Things that go bump in the night: the parasomnias revisited.  J Clin Neurophysiol. 1990;  7(1) 119-143
• 25 Kahn E, Fisher C, Edwards A. Night terrors and anxiety dreams. In: Ellman SD, Antrobus JS The Mind in Sleep Psychology and Psychophysiology. 2nd ed. New York; John Wiley & Sons 1991: 437-447
• 26 Mahowald M W, Bundlie S R, Hurwitz T D, Schenck C H. Sleep violence—forensic science implications: polygraphic and video documentation.  J Forensic Sci. 1990;  35(2) 413-432
• 27 Mahowald M W, Schenck C H, Goldner M, Bachelder V, Cramer-Bornemann M. Parasomnia pseudo-suicide.  J Forensic Sci. 2003;  48(5) 1158-1162
• 28 Mahowald M W, Schenck C H. NREM sleep parasomnias.  Neurol Clin. 1996;  14(4) 675-696
• 29 Aldrich M S. Sleep Medicine. Oxford/New York; Oxford University Press 1999
• 30 Wise M S. Parasomnias in children.  Pediatr Ann. 1997;  26(7) 427-433
• 31 Koran L M, Raghavan S. Fluoxetine for isolated sleep paralysis.  Psychosomatics. 1993;  34(2) 184-187
• 32 Ohayon M M, Caulet M, Priest R G. Violent behavior during sleep.  J Clin Psychiatry. 1997;  58(8) 369-376, quiz 377
• 33 Comella C L, Nardine T M, Diederich N J, Stebbins G T. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease.  Neurology. 1998;  51(2) 526-529
• 34 Eisensehr I, Parrino L, Noachtar S, Smerieri A, Terzano M G. Sleep in Lennox-Gastaut syndrome: the role of the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes.  Epilepsy Res. 2001;  46(3) 241-250
• 35 Tachibana M, Tanaka K, Hishikawa Y, Kaneko Z. A sleep study of acute psychotic states due to alcohol and meprobamate addiction.  Adv Sleep Res. 1975;  2 177-205
• 36 Passouant P, Cadilhac J, Ribstein M. Les privations de sommeil avec mouvements oculaires par les anti-depresseurs.  Rev Neurol (Paris). 1972;  127 173-192
• 37 Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride.  Acta Neurol Scand. 1976;  54(1) 71-87
• 38 Besset A. Effect of antidepressants on human sleep.  Adv Biosci. 1978;  21 141-148
• 39 Shimizu T, Ookawa M, Iijuma S et al.. Effect of clomipramine on nocturnal sleep of normal human subjects.  Ann Rev Pharmacopsychiat Res Found. 1985;  16 138
• 40 Bental E, Lavie P, Sharf B. Severe hypermotility during sleep in treatment of cataplexy with clomipramine.  Isr J Med Sci. 1979;  15(7) 607-609
• 41 Akindele M O, Evans J I, Oswald I. Mono-amine oxidase inhibitors, sleep and mood.  Electroencephalogr Clin Neurophysiol. 1970;  29 47-56
• 42 Carlander B, Touchon J, Ondze B, Billiard M. REM sleep behavior disorder induced by cholinergic treatment in Alzheimer's disease.  J Sleep Res. 1996;  5(S1) 28
• 43 Ross J S, Shua-Haim J R. Aricept-induced nightmares in Alzheimer's disease: 2 case reports.  J Am Geriatr Soc. 1998;  46(1) 119-120
• 44 Schenck C H, Mahowald M W, Kim S W, O'Connor K A, Hurwitz T D. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder.  Sleep. 1992;  15(3) 226-235
• 45 Schutte S, Doghramji K. REM behavior disorder seen with venlafaxine (Effexor).  Sleep Res. 1996;  25 364
• 46 Stolz S E, Aldrich M S. REM sleep behavior disorder associated with caffeine abuse.  Sleep Res. 1991;  20 341
• 47 Vorona R D, Ware J C. Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report.  Sleep Med. 2002;  3(4) 365-367
• 48 Friedman J H. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3).  Mov Disord. 2002;  17(6) 1350-1353
• 49 Schenck C H, Bundlie S R, Patterson A L, Mahowald M W. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults.  JAMA. 1987;  257(13) 1786-1789
• 50 Xi Z, Luning W. REM sleep behavior disorder in a patient with pontine stroke.  Sleep Med. 2009;  10(1) 143-146
• 51 Schenck C H, Mahowald M W. Rapid eye movement sleep parasomnias.  Neurol Clin. 2005;  23(4) 1107-1126
• 52 Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis.  Sleep Med. 2002;  3(5) 437-439
• 53 Pareja J A, Caminero A B, Masa J F, Dobato J L. A first case of progressive supranuclear palsy and pre-clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep.  Neurologia. 1996;  11(8) 304-306
• 54 Boeve B F, Silber M H, Ferman T J, Lucas J A, Parisi J E. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.  Mov Disord. 2001;  16(4) 622-630
• 55 Boeve B F, Silber M H, Parisi J E et al.. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.  Neurology. 2003;  61 40-45
• 56 Schenck C H, Bundlie S R, Mahowald M W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.  Neurology. 1996;  46(2) 388-393
• 57 Montplaisir J, Petit D, Décary A et al.. Sleep and quantitative EEG in patients with progressive supranuclear palsy.  Neurology. 1997;  49(4) 999-1003
• 58 Nevsimalova S, Prihodova I, Kemlink D, Lin L, Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy.  Sleep Med. 2007;  8(7-8) 784-786
• 59 Schenck C H, Mahowald M W. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder.  Ann Neurol. 1992;  32(1) 3-10
• 60 Abad V C, Guilleminault C. Review of rapid eye movement behavior sleep disorders.  Curr Neurol Neurosci Rep. 2004;  4(2) 157-163
• 61 Ozekmekçi S, Apaydin H, Kiliç E. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.  Clin Neurol Neurosurg. 2005;  107(4) 306-309
• 62 Jouvet M, Delorme F. Locus coeruleus et sommeil paradoxal.  C R Soc Biol (Paris). 1965;  159 895-899
• 63 Schenck C H, Bundlie S R, Ettinger M G, Mahowald M W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia.  Sleep. 1986;  9(2) 293-308
• 64 Paparrigopoulos T J. REM sleep behaviour disorder: clinical profiles and pathophysiology.  Int Rev Psychiatry. 2005;  17(4) 293-300
• 65 Mahowald M, Schenck C. REM sleep parasomnias. In: Kryger M, Dement W Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia; WB Saunders 2000: 724-737
• 66 Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus F J, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.  Brain. 2000;  123(Pt 6) 1155-1160
• 67 Eisensehr I, Linke R, Tatsch K et al.. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.  Sleep. 2003;  26(5) 507-512
• 68 Albin R L, Koeppe R A, Chervin R D et al.. Decreased striatal dopaminergic innervation in REM sleep behavior disorder.  Neurology. 2000;  55(9) 1410-1412
• 69 Gilman S, Koeppe R A, Chervin R D et al.. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.  Neurology. 2003;  61(1) 29-34
• 70 Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases.  Sleep Med Rev. 2009;  , April 8 (Epub ahead of print)
• 71 Fantini M L, Gagnon J F, Petit D et al.. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder.  Ann Neurol. 2003;  53(6) 774-780
• 72 Schenck C H, Mahowald M W. REM sleep parasomnias.  Neurol Clin. 1996;  14(4) 697-720
• 73 Schenck C H, Mahowald M W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.  Sleep. 2002;  25(2) 120-138
• 74 Mahowald M W. Parasomnias.  Med Clin North Am. 2004;  88(3) 669-678, ix
• 75 Bonakis A, Howard R S, Ebrahim I O, Merritt S, Williams A. REM sleep behaviour disorder (RBD) and its associations in young patients.  Sleep Med. 2009;  10(6) 641-645
• 76 Stores G. Rapid eye movement sleep behaviour disorder in children and adolescents.  Dev Med Child Neurol. 2008;  50(10) 728-732
• 77 Schenck C H, Mahowald M W. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients.  Cleve Clin J Med. 1990;  57(Suppl) S9-S23
• 78 Mahowald M W, Schenck C H. REM Sleep Behavior Disorder. Philadelphia; WB Saunders 1994
• 79 Takeuchi N, Uchimura N, Hashizume Y et al.. Melatonin therapy for REM sleep behavior disorder.  Psychiatry Clin Neurosci. 2001;  55(3) 267-269
• 80 Boeve B. Melatonin for treatment of REM sleep behavior disorder: response in 8 patients.  Sleep. 2001;  24(Suppl) A35
• 81 Schmidt M H, Koshal V B, Schmidt H S. Use of pramipexole in REM sleep behavior disorder: results from a case series.  Sleep Med. 2006;  7(5) 418-423
• 82 Fantini M L, Gagnon J F, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder.  Neurology. 2003;  61(10) 1418-1420
• 83 Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.  Mov Disord. 1996;  11(2) 214-216
• 84 Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.  Mov Disord. 1996;  11(2) 214-216
• 85 Shneerson J M. Successful treatment of REM sleep behavior disorder with sodium oxybate.  Clin Neuropharmacol. 2009;  32(3) 158-159
• 86 Taylor-Gjevre R M, Gjevre J A, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort.  J Clin Rheumatol. 2009;  15(1) 12-15
• 87 Lesage S, Hening W A. The restless legs syndrome and periodic limb movement disorder: a review of management.  Semin Neurol. 2004;  24(3) 249-259
• 88 Rothdach A J, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.  Neurology. 2000;  54(5) 1064-1068
• 89 Tan E K, Seah A, See S J, Lim E, Wong M C, Koh K K. Restless legs syndrome in an Asian population: a study in Singapore.  Mov Disord. 2001;  16(3) 577-579
• 90 Sevim S, Dogu O, Camdeviren H et al.. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.  Neurology. 2003;  61(11) 1562-1569
• 91 Krishnan P R, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study.  Mov Disord. 2003;  18(2) 181-185
• 92 Chaudhuri K R, Forbes A, Grosset D et al.. Diagnosing restless legs syndrome (RLS) in primary care.  Curr Med Res Opin. 2004;  20(11) 1785-1795
• 93 Allen R P, Picchietti D, Hening W A, Trenkwalder C, Walters A S, Montplaisi J. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.  Sleep Med. 2003;  4(2) 101-119
• 94 Gamaldo C E, Earley C J. Restless legs syndrome: a clinical update.  Chest. 2006;  130(5) 1596-1604
• 95 Allen R P, Earley C J. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset.  Sleep Med. 2000;  1(1) 11-19
• 96 Abetz L, Allen R, Follet A et al.. Evaluating the quality of life of patients with restless legs syndrome.  Clin Ther. 2004;  26(6) 925-935
• 97 Saletu M, Anderer P, Saletu B, Lindeck-Pozza L, Hauer C, Saletu-Zyhlarz G. EEG mapping in patients with restless legs syndrome as compared with normal controls.  Psychiatry Res. 2002;  115(1-2) 49-61
• 98 Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population.  Arch Intern Med. 2004;  164(2) 196-202
• 99 Becker P M. The biopsychosocial effects of restless legs syndrome (RLS).  Neuropsychiatr Dis Treat. 2006;  2(4) 505-512
• 100 Baier P C, Trenkwalder C. Circadian variation in restless legs syndrome.  Sleep Med. 2007;  8(6) 645-650
• 101 Garcia-Borreguero D, Larrosa O, de la Llave Y. Circadian aspects in the pathophysiology of the restless legs syndrome.  Sleep Med. 2002;  3(Suppl) S17-S21
• 102 Poceta J S, Parsons L, Engelland S, Kripke D F. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.  Sleep Med. 2009;  10(1) 129-133
• 103 Earley C J, Allen R P, Beard J L, Connor J R. Insight into the pathophysiology of restless legs syndrome.  J Neurosci Res. 2000;  62(5) 623-628
• 104 Earley C J, Connors J R, Allen R P. RLS patients have abnormally reduced CSF ferritin compared to normal controls.  Neurology. 1999;  52(Suppl 2) A111-A112
• 105 Miyamoto M, Miyamoto T, Iwanami M, Suzuki K, Hirata K. [The pathophysiology of restless legs syndrome].  Brain Nerve. 2009;  61(5) 523-532
• 106 Karroum E, Konofal E, Arnulf I. [Restless-legs syndrome].  Rev Neurol (Paris). 2008;  164(8-9) 701-721
• 107 Smith J E, Tolson J M. Recognition, diagnosis, and treatment of restless legs syndrome.  J Am Acad Nurse Pract. 2008;  20(8) 396-401
• 108 Whittom S, Dauvilliers Y, Pennestri M H et al.. Age-at-onset in restless legs syndrome: a clinical and polysomnographic study.  Sleep Med. 2007;  9(1) 54-59
• 109 Winkelmann J. Genetics of restless legs syndrome.  Curr Neurol Neurosci Rep. 2008;  8(3) 211-216
• 110 Trenkwalder C, Högl B, Winkelmann J. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.  J Neurol. 2009;  256(4) 539-553
• 111 Pichler I, Hicks A A, Pramstaller P P. Restless legs syndrome: an update on genetics and future perspectives.  Clin Genet. 2008;  73(4) 297-305
• 112 Winkelmann J, Lichtner P, Schormair B et al.. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.  Mov Disord. 2008;  23(3) 350-358
• 113 Lohmann-Hedrich K, Neumann A, Kleensang A et al.. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci?.  Neurology. 2008;  70(9) 686-694
• 114 Kemlink D, Polo O, Frauscher B et al.. Replication of restless legs syndrome loci in three European populations.  J Med Genet. 2009;  46(5) 315-318
• 115 Yee B, Killick R, Wong K. Restless legs syndrome.  Aust Fam Physician. 2009;  38(5) 296-300
• 116 Al-Jahdali H H, Al-Qadhi W A, Khogeer H A, Al-Hejaili F F, Al-Ghamdi S M, Al Sayyari A A. Restless legs syndrome in patients on dialysis.  Saudi J Kidney Dis Transpl. 2009;  20(3) 378-385
• 117 Kim J M, Kwon H M, Lim C S, Kim Y S, Lee S J, Nam H. Restless legs syndrome in patients on hemodialysis: symptom severity and risk factors.  J Clin Neurol. 2008;  4(4) 153-157
• 118 Hui D S, Wong T Y, Ko F W et al.. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis.  Am J Kidney Dis. 2000;  36(4) 783-788
• 119 Hui D S, Wong T Y, Li T S et al.. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis.  Med Sci Monit. 2002;  8(5) CR331-CR336
• 120 Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand G F, Oertel W H, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome.  Am J Kidney Dis. 1998;  31(2) 324-328
• 121 Lee K A, Zaffke M E, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron.  J Womens Health Gend Based Med. 2001;  10(4) 335-341
• 122 Suzuki K, Ohida T, Sone T et al.. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems.  Sleep. 2003;  26(6) 673-677
• 123 Winkelman J W, Chertow G M, Lazarus J M. Restless legs syndrome in end-stage renal disease.  Am J Kidney Dis. 1996;  28(3) 372-378
• 124 Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.  Mov Disord. 2002;  17(5) 1072-1076
• 125 Ondo W G, Vuong K D, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome.  Arch Neurol. 2002;  59(3) 421-424
• 126 Abele M, Bürk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3.  J Neurol. 2001;  248(4) 311-314
• 127 Schöls L, Haan J, Riess O, Amoiridis G, Przuntek H. Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?.  Neurology. 1998;  51(6) 1603-1607
• 128 Banno K, Delaive K, Walld R, Kryger M H. Restless legs syndrome in 218 patients: associated disorders.  Sleep Med. 2000;  1(3) 221-229
• 129 Ağargün M Y, Kara H, Ozbek H, Tombul T, Ozer O A. Restless legs syndrome induced by mirtazapine.  J Clin Psychiatry. 2002;  63(12) 1179
• 130 Bakshi R. Fluoxetine and restless legs syndrome.  J Neurol Sci. 1996;  142(1-2) 151-152
• 131 Hargrave R, Beckley D J. Restless leg syndrome exacerbated by sertraline.  Psychosomatics. 1998;  39(2) 177-178
• 132 Sanz-Fuentenebro F J, Huidobro A, Tejadas-Rivas A. Restless legs syndrome and paroxetine.  Acta Psychiatr Scand. 1996;  94(6) 482-484
• 133 Santos B, Oliveira A S, Canhão C et al.. [Restless legs syndrome].  Acta Med Port. 2008;  21(4) 359-366
• 134 Hening W A, Allen R P, Chaudhuri K R et al.. Clinical significance of RLS.  Mov Disord. 2007;  22(Suppl 18) S395-S400
• 135 Karatas M. Restless legs syndrome and periodic limb movements during sleep: diagnosis and treatment.  Neurologist. 2007;  13(5) 294-301
• 136 Hening W, Allen R P, Tenzer P, Winkelman J W. Restless legs syndrome: demographics, presentation, and differential diagnosis.  Geriatrics. 2007;  62(9) 26-29
• 137 Lesage S, Earley C J. Restless legs syndrome.  Curr Treat Options Neurol. 2004;  6(3) 209-219
• 138 Tan E K, Ondo W. Restless legs syndrome: clinical features and treatment.  Am J Med Sci. 2000;  319(6) 397-403
• 139 Chesson Jr A L, Ferber R A, Fry J M et al.. The indications for polysomnography and related procedures.  Sleep. 1997;  20(6) 423-487
• 140 Littner M, Hirshkowitz M, Kramer M American Academy of Sleep Medicine et al. Practice parameters for using polysomnography to evaluate insomnia: an update.  Sleep. 2003;  26(6) 754-760
• 141 Kohnen R, Allen R P, Benes H et al.. Assessment of restless legs syndrome—methodological approaches for use in practice and clinical trials.  Mov Disord. 2007;  22(Suppl 18) S485-S494
• 142 Trenkwalder C, Kohnen R, Allen R P et al.. Clinical trials in restless legs syndrome—recommendations of the European RLS Study Group (EURLSSG).  Mov Disord. 2007;  22(Suppl 18) S495-S504
• 143 Khan S A, Mettu K, Raja F. The restless legs syndrome: diagnosis and treatment.  Mo Med. 2006;  103(5) 518-522
• 144 Allen R P. Improving RLS diagnosis and severity assessment: polysomnography, actigraphy and RLS-sleep log.  Sleep Med. 2007;  8(Suppl 2) S13-S18
• 145 O'Keeffe S T, Gavin K, Lavan J N. Iron status and restless legs syndrome in the elderly.  Age Ageing. 1994;  23(3) 200-203
• 146 Sun E R, Chen C A, Ho G, Earley C J, Allen R P. Iron and the restless legs syndrome.  Sleep. 1998;  21(4) 371-377
• 147 Trenkwalder C, Hening W A, Montagna P et al.. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.  Mov Disord. 2008;  23(16) 2267-2302
• 148 Schapira A H. Restless legs syndrome: an update on treatment options.  Drugs. 2004;  64(2) 149-158
• 149 Silber M H, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study.  Sleep. 2003;  26(7) 819-821
• 150 Mitler M M, Browman C P, Menn S J, Gujavarty K, Timms R M. Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.  Sleep. 1986;  9(3) 385-392
• 151 Kaplan P W, Allen R P, Buchholz D W, Walters J K. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.  Sleep. 1993;  16(8) 717-723
• 152 Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. An American Academy of Sleep Medicine Review . The treatment of restless legs syndrome and periodic limb movement disorder.  Sleep. 1999;  22(7) 970-999
• 153 Hening W A, Allen R P, Earley C J, Picchietti D L, Silber M. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine interim review.  Sleep. 2004;  27(3) 560-583
• 154 Byrne R, Sinha S, Chaudhuri K R. Restless legs syndrome: diagnosis and review of management options.  Neuropsychiatr Dis Treat. 2006;  2(2) 155-164
• 155 Allen R P, Earley C J. Augmentation of the restless legs syndrome with carbidopa/levodopa.  Sleep. 1996;  19(3) 205-213
• 156 Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.  Neurology. 2002;  59(10) 1573-1579
• 157 Sommer M, Bachmann C G, Liebetanz K M, Schindehütte J, Tings T, Paulus W. Pregabalin in restless legs syndrome with and without neuropathic pain.  Acta Neurol Scand. 2007;  115(5) 347-350
• 158 Kavey N, Walters A S, Hening W, Gidro-Frank S. Opioid treatment of periodic movements in sleep in patients without restless legs.  Neuropeptides. 1988;  11(4) 181-184
• 159 Recording and scoring leg movements. The Atlas Task Force.  Sleep. 1993;  16(8) 748-759
• 160 Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment.  Sleep Med Rev. 2006;  10(3) 169-177
• 161 Wetter T C, Pollmächer T. Restless legs and periodic leg movements in sleep syndromes.  J Neurol. 1997;  244(4, Suppl 1) S37-S45
• 162 Ohayon M M, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population.  J Psychosom Res. 2002;  53(1) 547-554
• 163 Hening W. The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization.  Clin Neurophysiol. 2004;  115(9) 1965-1974
• 164 Anonymous .ICSD-2—The International Classification of Sleep Disorders, Second Edition: Diagnostic and Coding Manual. Westchester, IL; American Academy of Sleep Medicine 2005
• 165 Ancoli-Israel S, Kripke D F, Mason W, Kaplan O J. Sleep apnea and periodic movements in an aging sample.  J Gerontol. 1985;  40(4) 419-425
• 166 Carelli G, Krieger J, Calvi-Gries F, Macher J P. Periodic limb movements and obstructive sleep apneas before and after continuous positive airway pressure treatment.  J Sleep Res. 1999;  8(3) 211-216
• 167 Ancoli-Israel S, Bliwise D L, Mant A. Sleep and Breathing in the Elderly. New York; Marcel Dekker Inc 1993
• 168 ManiIa M N. Leg cramps in relation to metabolic syndrome.  Georgian Med News. 2009;  (166) 51-54
• 169 Nocturnal leg cramps.  Postgrad Med. 2002;  111(2) 125-126
• 170 Butler J V, Mulkerrin E C, O'Keeffe S T. Nocturnal leg cramps in older people.  Postgrad Med J. 2002;  78(924) 596-598
• 171 Kelly J. Nocturnal leg cramps in the elderly.  N Z Med J. 1995;  108(1000) 207
• 172 Brasić J R. Quinine-induced thrombocytopenia in a 64-year-old man who consumed tonic water to relieve nocturnal leg cramps.  Mayo Clin Proc. 2001;  76(8) 863-864
• 173 Crum N F, Gable P. Quinine-induced hemolytic-uremic syndrome.  South Med J. 2000;  93(7) 726-728
• 174 Mandal A K, Abernathy T, Nelluri S N, Stitzel V. Is quinine effective and safe in leg cramps?.  J Clin Pharmacol. 1995;  35(6) 588-593
• 175 Guay D R. Are there alternatives to the use of quinine to treat nocturnal leg cramps?.  Consult Pharm. 2008;  23(2) 141-156
• 176 Del Mar C B, Glasziou P P, Spinks A B, Sanders S L, Hilton D J. Treatment alternatives for nocturnal leg cramps.  Med J Aust. 2001;  174(10) 540
• 177 Voon W C, Sheu S H. Diltiazem for nocturnal leg cramps.  Age Ageing. 2001;  30(1) 91-92
• 178 Vetrugno R, Provini F, Meletti S et al.. Propriospinal myoclonus at the sleep-wake transition: a new type of parasomnia.  Sleep. 2001;  24(7) 835-843
• 179 Vetrugno R, Provini F, Meletti S et al.. Propriospinal myoclonus at the sleep-wake transition: a new type of parasomnia.  Sleep. 2001;  24(7) 835-843
• 180 Plazzi G, Provini F, Ligouri R, Lugaresi E, Montagna P. Propriospinal myoclonus at the transition from wake to sleep.  Sleep Res. 1996;  26 438
• 181 Montagna P, Provini F, Plazzi G, Liguori R, Lugaresi E. Propriospinal myoclonus upon relaxation and drowsiness: a cause of severe insomnia.  Mov Disord. 1997;  12(1) 66-72
• 182 Rugh J D, Harlan J. Nocturnal bruxism and temporomandibular disorders.  Adv Neurol. 1988;  49 329-341
• 183 Gerber P E, Lynd L D. Selective serotonin-reuptake inhibitor-induced movement disorders.  Ann Pharmacother. 1998;  32(6) 692-698
• 184 Ellison J M, Stanziani P. SSRI-associated nocturnal bruxism in four patients.  J Clin Psychiatry. 1993;  54(11) 432-434
• 185 Lang R, White P J, Machalicek W et al.. Treatment of bruxism in individuals with developmental disabilities: a systematic review.  Res Dev Disabil. 2009;  30(5) 809-818
• 186 Ommerborn M A, Schneider C, Giraki M et al.. Effects of an occlusal splint compared with cognitive-behavioral treatment on sleep bruxism activity.  Eur J Oral Sci. 2007;  115(1) 7-14
• 187 Monroy P G, da Fonseca M A. The use of botulinum toxin-a in the treatment of severe bruxism in a patient with autism: a case report.  Spec Care Dentist. 2006;  26(1) 37-39
• 188 Nash M C, Ferrell R B, Lombardo M A, Williams R B. Treatment of bruxism in Huntington's disease with botulinum toxin.  J Neuropsychiatry Clin Neurosci. 2004;  16(3) 381-382
• 189 Foster P S. Use of the Calmset 3 biofeedback/relaxation system in the assessment and treatment of chronic nocturnal bruxism.  Appl Psychophysiol Biofeedback. 2004;  29(2) 141-147
• 190 van der Meulen M J, Lobbezoo F, Naeije M. [Role of the psychologist in the treatment of bruxism].  Ned Tijdschr Tandheelkd. 2000;  107(7) 297-300
• 191 Thompson B A, Blount B W, Krumholz T S. Treatment approaches to bruxism.  Am Fam Physician. 1994;  49(7) 1617-1622
• 192 Happe S, Lüdemann P, Ringelstein E B. Persistence of rhythmic movement disorder beyond childhood: a videotape demonstration.  Mov Disord. 2000;  15(6) 1296-1298
• 193 Kohyama J, Matsukura F, Kimura K, Tachibana N. Rhythmic movement disorder: polysomnographic study and summary of reported cases.  Brain Dev. 2002;  24(1) 33-38
• 194 Kotagal S. Parasomnias of childhood.  Curr Opin Pediatr. 2008;  20(6) 659-665
• 195 Stepanova I, Nevsimalova S, Hanusova J. Rhythmic movement disorder in sleep persisting into childhood and adulthood.  Sleep. 2005;  28(7) 851-857
• 196 Wiggs L. Behavioural aspects of children's sleep.  Arch Dis Child. 2009;  94(1) 59-62
• 197 Kempenaers C, Bouillon E, Mendlewicz J. A rhythmic movement disorder in REM sleep: a case report.  Sleep. 1994;  17(3) 274-279
• 198 Gagnon P, De Koninck J. Repetitive head movements during REM sleep.  Biol Psychiatry. 1985;  20(2) 176-178
• 199 Kuhn B R, Elliott A J. Treatment efficacy in behavioral pediatric sleep medicine.  J Psychosom Res. 2003;  54(6) 587-597
• 200 Hoban T F. Rhythmic movement disorder in children.  CNS Spectr. 2003;  8(2) 135-138
• 201 Gharagozlou P, Seyffert M, Santos R, Chokroverty S. Rhythmic movement disorder associated with respiratory arousals and improved by CPAP titration in a patient with restless legs syndrome and sleep apnea.  Sleep Med. 2009;  10(4) 501-503
• 202 Reimão R N, Lefévre A B. Prevalence of sleep-talking in childhood.  Brain Dev. 1980;  2(4) 353-357
• 203 Ogden T H. On talking-as-dreaming.  Int J Psychoanal. 2007;  88(Pt 3) 575-589
• 204 Arkin A M. Sleep-talking: a review.  J Nerv Ment Dis. 1966;  143(2) 101-122
• 205 Rechtschaffen A, Goodenough D R, Shapiro A. Patterns of sleep talking.  Arch Gen Psychiatry. 1962;  7 418-426
• 206 Leo G. Parasomnias.  WMJ. 2003;  102(1) 32-35
• 207 Clouston P D, Lim C L, Fung V, Yiannikas C, Morris J G. Brainstem myoclonus in a patient with non-dopa-responsive parkinsonism.  Mov Disord. 1996;  11(4) 404-410
• 208 Bruno R L. Abnormal movements in sleep as a post-polio sequelae.  Am J Phys Med Rehabil. 1998;  77(4) 339-343
• 209 Bruni O, Galli F, Guidetti V. Sleep hygiene and migraine in children and adolescents.  Cephalalgia. 1999;  19(Suppl 25) 57-59
• 210 Walters A S. Clinical identification of the simple sleep-related movement disorders.  Chest. 2007;  131(4) 1260-1266
• 211 Kotagal P, Costa M, Wyllie E, Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents.  Pediatrics. 2002;  110(4) e46
• 212 Sander H W, Geisse H, Quinto C, Sachdeo R, Chokroverty S. Sensory sleep starts.  J Neurol Neurosurg Psychiatry. 1998;  64(5) 690
• 213 Montagna P. Sleep-related non epileptic motor disorders.  J Neurol. 2004;  251(7) 781-794
• 214 Vaccario M L, Valenti M A, Carullo A, Di Bartolomeo R, Mazza S. Benign neonatal sleep myoclonus: case report and follow-up of four members of an affected family.  Clin Electroencephalogr. 2003;  34(1) 15-17
• 215 Lins O, Castonguay M, Dunham W, Nevsimalova S, Broughton R. Excessive fragmentary myoclonus: time of night and sleep stage distributions.  Can J Neurol Sci. 1993;  20(2) 142-146
• 216 Vetrugno R, Plazzi G, Provini F, Liguori R, Lugaresi E, Montagna P. Excessive fragmentary hypnic myoclonus: clinical and neurophysiological findings.  Sleep Med. 2002;  3(1) 73-76
• 217 Vetrugno R, Provini F, Plazzi G, Vignatelli L, Lugaresi E, Montagna P. Catathrenia (nocturnal groaning): a new type of parasomnia.  Neurology. 2001;  56(5) 681-683
• 218 Vetrugno R, Lugaresi E, Ferini-Strambi L, Montagna P. Catathrenia (nocturnal groaning): what is it?.  Sleep. 2008;  31(3) 308-309
• 219 Manconi M, Zucconi M, Carrot B, Ferri R, Oldani A, Ferini-Strambi L. Association between bruxism and nocturnal groaning.  Mov Disord. 2008;  23(5) 737-739
• 220 Vetrugno R, Lugaresi E, Plazzi G, Provini F, D'Angelo R, Montagna P. Catathrenia (nocturnal groaning): an abnormal respiratory pattern during sleep.  Eur J Neurol. 2007;  14(11) 1236-1243
• 221 Vetrugno R, Provini F, Plazzi G, Vignatelli L, Lugaresi E, Montagna P. Catathrenia (nocturnal groaning): a new type of parasomnia.  Neurology. 2001;  56(5) 681-683
• 222 DeRoeck J, Van Hoof E, Cluydts R. Sleep-related expiratory groaning: a case report.  Sleep Res. 1983;  12 237
• 223 Provini F, Plazzi G, Montagna P, Lugaresi E. The wide clinical spectrum of nocturnal frontal lobe epilepsy.  Sleep Med Rev. 2000;  4(4) 375-386
• 224 Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome.  Adv Neurol. 1986;  43 295-307
• 225 Hirsch E, Sellal F, Maton B, Rumbach L, Marescaux C. Nocturnal paroxysmal dystonia: a clinical form of focal epilepsy.  Neurophysiol Clin. 1994;  24(3) 207-217